(Bloomberg) -- Roche Holding AG Chairman Christoph Franz expects a breakthrough in finding a treatment for Alzheimer's disease in the coming years, he tells SonntagsZeitung in an interview.
The fact that we can now diagnose the disease will help in the efforts to find a treatment, he told the Swiss newspaper. “With a trial, we therefore finally know whether the test person really has Alzheimer's or is suffering from another form of dementia.”
Read More: Why Big Pharma Is Willing to Lose Fortune Seeking Alzheimer Cure
Roche has two drugs in the final stage phase of tests for the disease, Franz said, without naming them.
Asked about a possible successor to Vice Chairman Andre Hoffmann, whose term ends this year, Franz said he would expect the Hoffmann family to decide on the succession in due course. Members of the Hoffmann family are among shareholders in the company.
To contact the reporter on this story: Catherine Bosley in Zurich at cbosley1@bloomberg.net
To contact the editors responsible for this story: Fergal O'Brien at fobrien@bloomberg.net, Rachel Graham, Steve Geimann
©2019 Bloomberg L.P.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
